ADVANCED BIOSCIENCE LABORATORIES, INC.

Advanced Bioscience Laboratories, Inc. specializes in end-to-end biopharmaceutical research and development services, with deep expertise in preclinical drug development, pharmacology studies, and animal model design. The company delivers critical support across the product lifecycle, including chemistry, manufacturing, and controls (CMC), formulation development, and toxicology profiling for biologics and small-molecule therapeutics. Their technical capabilities extend to the application of artificial intelligence and machine learning for pharmaceutical data enhancement, particularly in pediatric excipient selection and lead candidate identification. They also provide specialized services in medicinal manufacturing, including the production of bulk HIV-1 antigens and in-vitro diagnostic substances, demonstrating proficiency in GMP-aligned processes and analytical validation. Their integrated approach bridges laboratory research with regulatory-ready deliverables, making them a trusted partner for complex, translationally focused projects. The contractor maintains a dominant relationship with the Department of Health and Human Services, consistently supporting its mission-critical drug development initiatives through agencies such as NIH and BARDA. Their work for HHS centers on advancing therapeutics for underserved populations, including pediatric formulations and novel biologics, often in support of public health emergency preparedness and rare disease programs. Industry focus is squarely on biotechnology research and development, with significant activity in pharmaceutical manufacturing and life sciences R&D. The company is positioned as a niche provider for non-nanotech, non-biotech-heavy biopharma projects, bridging discovery and early-stage development with scalable manufacturing readiness. Their work spans both biological and chemical entities, with particular strength in antibody therapeutics and oligonucleotide-based modalities. As a small business structured as a 2L entity based in Potomac, Maryland, Advanced Bioscience Laboratories operates with agility and deep scientific rigor. While currently holding no formal government certifications, their consistent performance on high-stakes HHS contracts underscores their reliability and technical credibility within the federal biopharma ecosystem.